Larbi El Mchichi, Mohammed Bouachrine, Tahar Lakhlifi

Gebundenes Buch

Anticancer Activity in Heterocyclic Organic Structures

A Pathway to Novel Drug Development Part 1

Beschreibung

This new volume in New Directions in Organic & Biological Chemistry, explores the development of cancer therapeutics, focusing on molecular chemistry and advanced drug design approaches.

Autor

Dr. Larbi EL Mchichi holds a PhD in Chemistry with a specialization in Theoretical Chemistry from Moulay Ismail University (Faculty of Sciences, Meknes). His doctoral research focused on the anticancer activity of heterocyclic organic molecules, using statistical and quantum methods, including QSAR modeling and molecular docking. In his research, Dr. EL Mchichi explores innovative computational approaches to the design of novel therapeutic agents, particularly anticancer compounds, utilizing techniques like 3D-QSAR, drug-likeness assessment, ADMET prediction, and molecular docking simulations. In addition to his research, he is a first-grade certified teacher of physics and chemistry at the secondary education level, where he strives to inspire his students with a passion for science and research. Dr. EL Mchichi has authored several peer-reviewed publications in international journals, including work on the design of pyrazole derivatives as anticancer agents and the discovery of a new isatin scaffold for BCR-ABL tyrosine kinase inhibitors. His research aims to contribute to the advancement of cutting-edge cancer therapies through the integration of computational methods and pharmaceutical science.

Produktdetails

• Verlag: CRC Press
• Seitenzahl: 184
• Erscheinungstermin: 4. November 2025
• Englisch
• ISBN-13: 9781041100584
• ISBN-10: 1041100582
• Artikelnr.: 74244978